Literature DB >> 30359137

Heart Disease and Cancer: Are the Two Killers Colluding?

Richard N Kitsis1, Jaime A Riquelme2, Sergio Lavandero2,3.   

Abstract

Entities:  

Keywords:  Editorials; SerpinA1 protein, human; ceruloplasmin; fibronectins; heart failure; transplantation, heterotopic

Mesh：

Year:  2018        PMID： 30359137      PMCID： PMC6277211          DOI： 10.1161/CIRCULATIONAHA.118.033907

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

Review 1.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.

Authors:  William Hankey; Wendy L Frankel; Joanna Groden
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

2.  Incident cancer in patients with heart failure: causation or mere association?

Authors:  Anita Deswal; Sukhdeep S Basra
Journal:  J Am Coll Cardiol       Date:  2013-06-27       Impact factor: 24.094

Review 3.  Cardiovascular Toxic Effects of Targeted Cancer Therapies.

Authors:  Javid J Moslehi
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

Review 4.  Associated Risk of Malignancy in Patients with Cardiovascular Disease: Evidence and Possible Mechanism.

Authors:  Tal Hasin; Zaza Iakobishvili; Giora Weisz
Journal:  Am J Med       Date:  2017-03-24       Impact factor: 4.965

5.  Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.

Authors:  H L Hillege; W M Janssen; A A Bak; G F Diercks; D E Grobbee; H J Crijns; W H Van Gilst; D De Zeeuw; P E De Jong
Journal:  J Intern Med       Date:  2001-06       Impact factor: 8.989

6.  Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.

Authors:  L K Su; K W Kinzler; B Vogelstein; A C Preisinger; A R Moser; C Luongo; K A Gould; W F Dove
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

Review 7.  Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors:  Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

Review 8.  ApcMin: a mouse model for intestinal and mammary tumorigenesis.

Authors:  A R Moser; C Luongo; K A Gould; M K McNeley; A R Shoemaker; W F Dove
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

9.  Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).

Authors:  Nicolas F Schroten; Willem P T Ruifrok; Lennaert Kleijn; Martin M Dokter; Herman H Silljé; Hiddo J Lambers Heerspink; Stephan J L Bakker; Ido P Kema; Wiek H van Gilst; Dirk J van Veldhuisen; Hans L Hillege; Rudolf A de Boer
Journal:  Am Heart J       Date:  2013-06-24       Impact factor: 4.749

10.  Patients with heart failure have an increased risk of incident cancer.

Authors:  Tal Hasin; Yariv Gerber; Sheila M McNallan; Susan A Weston; Sudhir S Kushwaha; Timothy J Nelson; James R Cerhan; Veronique L Roger
Journal:  J Am Coll Cardiol       Date:  2013-06-27       Impact factor: 24.094
View more
  14 in total

1.  Role of cellular retinol-binding protein, type 1 and retinoid homeostasis in the adult mouse heart: A multi-omic approach.

Authors:  Stephanie Zalesak-Kravec; Weiliang Huang; Jace W Jones; Jianshi Yu; Jenna Alloush; Amy E Defnet; Alexander R Moise; Maureen A Kane
Journal:  FASEB J       Date:  2022-04       Impact factor: 5.834

Review 2.  Common risk factors for heart failure and cancer.

Authors:  Wouter C Meijers; Rudolf A de Boer
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

3.  Cancer and heart disease: associations and relations.

Authors:  Rudolf A de Boer; Wouter C Meijers; Peter van der Meer; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2019-07-18       Impact factor: 15.534

4.  Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.

Authors:  Sofia Ajeganova; Ingiäld Hafström; Johan Frostegård
Journal:  Lupus Sci Med       Date:  2021-02

5.  Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy.

Authors:  Hsien-Yuan Chang; Chun-Hui Lee; Po-Lan Su; Sin-Syue Li; Ming-Yueh Chen; Ya-Ping Chen; Ya-Ting Hsu; Wei-Chuan Tsai; Ping-Yen Liu; Tsai-Yun Chen; Yen-Wen Liu
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

Review 6.  Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications.

Authors:  Alessandra Cuomo; Flora Pirozzi; Umberto Attanasio; Riccardo Franco; Francesco Elia; Eliana De Rosa; Michele Russo; Alessandra Ghigo; Pietro Ameri; Carlo Gabriele Tocchetti; Valentina Mercurio
Journal:  Curr Oncol Rep       Date:  2020-12-02       Impact factor: 5.075

Review 7.  Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork.

Authors:  Simonetta Ausoni; Giuseppe Azzarello
Journal:  Front Cardiovasc Med       Date:  2020-10-26

8.  Tumour biomarkers: association with heart failure outcomes.

Authors:  C Shi; H H van der Wal; H H W Silljé; M M Dokter; F van den Berg; L Huizinga; M Vriesema; J Post; S D Anker; J G Cleland; L L Ng; N J Samani; K Dickstein; F Zannad; C C Lang; P L van Haelst; J A Gietema; M Metra; P Ameri; M Canepa; D J van Veldhuisen; A A Voors; R A de Boer
Journal:  J Intern Med       Date:  2020-05-05       Impact factor: 8.989

9.  Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Rudolf A de Boer; Jean-Sébastien Hulot; Carlo Gabriele Tocchetti; Joseph Pierre Aboumsallem; Pietro Ameri; Stefan D Anker; Johann Bauersachs; Edoardo Bertero; Andrew J S Coats; Jelena Čelutkienė; Ovidiu Chioncel; Pierre Dodion; Thomas Eschenhagen; Dimitrios Farmakis; Antoni Bayes-Genis; Dirk Jäger; Ewa A Jankowska; Richard N Kitsis; Suma H Konety; James Larkin; Lorenz Lehmann; Daniel J Lenihan; Christoph Maack; Javid J Moslehi; Oliver J Müller; Patrycja Nowak-Sliwinska; Massimo Francesco Piepoli; Piotr Ponikowski; Radek Pudil; Peter P Rainer; Frank Ruschitzka; Douglas Sawyer; Petar M Seferovic; Thomas Suter; Thomas Thum; Peter van der Meer; Linda W Van Laake; Stephan von Haehling; Stephane Heymans; Alexander R Lyon; Johannes Backs
Journal:  Eur J Heart Fail       Date:  2020-11-12       Impact factor: 15.534

Review 10.  New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management.

Authors:  Alessandra Cuomo; Francesca Paudice; Giovanni D'Angelo; Giovanni Perrotta; Antonio Carannante; Umberto Attanasio; Martina Iengo; Francesco Fiore; Carlo Gabriele Tocchetti; Valentina Mercurio; Flora Pirozzi
Journal:  Curr Heart Fail Rep       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.